Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ravaioli

Showing results (251-260 of 300) with videos related to

Pageof 30
Sort By:
Scientific Reports|September 14, 2017
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantationMatteo Ravaioli, Alessandro Cucchetti, Antonio Daniele Pinna, et al.
Transplantation Proceedings|April 15, 2026
Flow Control and Oxygenation of Preservation Solution in Circulatory Determined Death Donors Undergoing Abdominal Normothermic Regional PerfusionMarta Velia Antonini, Alessandro Circelli, Gaetano La Manna, et al.
Journal of Hepatology|March 24, 2020
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplantAlessandro Cucchetti, Matteo Serenari, Carlo Sposito, et al.
Molecular Biology Reports|September 5, 2020
Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot studySirio Fiorino, Michela Visani, Michele Masetti, et al.
Artificial Organs|April 28, 2026
Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian InstitutionGerti Dajti, Giuliana Germinario, Enrico Prosperi, et al.
Cancer Research|February 5, 2020
MiR-30e-3p Influences Tumor Phenotype through <i>MDM2</i>/<i>TP53</i> Axis and Predicts Sorafenib Resistance in Hepatocellular CarcinomaLaura Gramantieri, Daniela Pollutri, Martina Gagliardi, et al.
Kidney International Reports|May 20, 2024
"Eculizumab First" in the Management of Posttransplant Thrombotic MicroangiopathyFederica Maritati, Valeria Corradetti, Claudia Bini, et al.
Chirurgia Italiana|April 9, 2008
[Minimally invasive adrenalectomy: transperitoneal vs. retroperitoneal approach]Giovanni Ramacciato, Giuseppe Nigri, Vincenzo Di Santo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2017
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated ApoptosisFrancesca Fornari, Daniela Pollutri, Clarissa Patrizi, et al.
Cancer Biomarkers : Section a of Disease Markers|November 6, 2017
Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4Michele Masetti, Giorgia Acquaviva, Michela Visani, et al.
Pageof 30

Showing results (251-260 of 300) with videos related to

Sort By:
Pageof 30
Scientific Reports|September 14, 2017
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantationMatteo Ravaioli, Alessandro Cucchetti, Antonio Daniele Pinna, et al.
Transplantation Proceedings|April 15, 2026
Flow Control and Oxygenation of Preservation Solution in Circulatory Determined Death Donors Undergoing Abdominal Normothermic Regional PerfusionMarta Velia Antonini, Alessandro Circelli, Gaetano La Manna, et al.
Journal of Hepatology|March 24, 2020
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplantAlessandro Cucchetti, Matteo Serenari, Carlo Sposito, et al.
Molecular Biology Reports|September 5, 2020
Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot studySirio Fiorino, Michela Visani, Michele Masetti, et al.
Artificial Organs|April 28, 2026
Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian InstitutionGerti Dajti, Giuliana Germinario, Enrico Prosperi, et al.
Cancer Research|February 5, 2020
MiR-30e-3p Influences Tumor Phenotype through <i>MDM2</i>/<i>TP53</i> Axis and Predicts Sorafenib Resistance in Hepatocellular CarcinomaLaura Gramantieri, Daniela Pollutri, Martina Gagliardi, et al.
Kidney International Reports|May 20, 2024
"Eculizumab First" in the Management of Posttransplant Thrombotic MicroangiopathyFederica Maritati, Valeria Corradetti, Claudia Bini, et al.
Chirurgia Italiana|April 9, 2008
[Minimally invasive adrenalectomy: transperitoneal vs. retroperitoneal approach]Giovanni Ramacciato, Giuseppe Nigri, Vincenzo Di Santo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2017
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated ApoptosisFrancesca Fornari, Daniela Pollutri, Clarissa Patrizi, et al.
Cancer Biomarkers : Section a of Disease Markers|November 6, 2017
Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4Michele Masetti, Giorgia Acquaviva, Michela Visani, et al.
Pageof 30